Infectious Diseases (except HIV/AIDS)
Showing page 714 of 716 pages of list content
-
Characteristics associated with household transmission of SARS-CoV-2 in Ontario, Canada
This article's authors -
Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19
This article's authors -
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
This article's authors -
SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies
This article's authors -
Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report
This article's authors -
First-in-Human Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
This article's authors -
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
This article's authors -
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
This article's authors -
Early Detection Of COVID-19 Using A Smartwatch
This article's authors -
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials
This article's authors